US-based company that deals with human-centred medical device development and regulatory services ClariMed, Inc. announced on Wednesday that it is opening its new office in Leeds, UK.
This move is intended to strengthen the company's European footprint and improve its ability to serve global customers while capitalising on the region's thriving healthcare innovation ecosystem.
The company says that the Leeds office is to serve as a hub for its expanding medical device user research capabilities, providing access to a diverse pool of study participants and enriching the firm's human factors engineering insights. It is to also function as a research facility to host usability and human factors studies to support design development, market research and human factors assessments.
Kelley Kendle, ClariMed CEO, said, 'This expansion not only broadens our geographical reach but also allows us to tap into the region's rich talent pool and innovative spirit. Leeds' strategic location and thriving healthcare sector align perfectly with our mission to drive human-centred innovation in medical device development.'
Breg names new chief executive officer and chief financial officer
Magellan Health launches Teen Mental Wellbeing app powered by BeMe
Azenta names new president and CEO
PHC announces launch of LiCellMo live cell metabolic analyzer targeting CGT advancements
Heron Therapeutics names new chief business officer
Expanse Medical names new chief executive officer and FlowPhysix board member
ClariMed opens new Leeds, UK office
Nightingale Health gains UKCA certification and expands with new laboratory
Talphera enrols first subject in NEPHRO CRRT study
China Pharma Holdings anticipates launch of Dry Eye Disease Therapeutic Device in early 2025
SOPHiA DDM Platform achieves IVDR certification, enhancing diagnostic precision
Medtronic reports FDA approval of Simplera CGM; partners with Abbott